MecideMericGhariboMD

PubMed

• 26 citations
  Avadomide monotherapy in relapsed/refractory DLBCL: safety, efficacy, and a predictive gene classifier.
  Cecilia Carpio, Reda Bouabdallah, Loic Ysebaert, Juan-Manuel Sancho, Gilles Salles, Raul Cordoba, Antonio Pinto, Mecide Gharibo, Drew W. Rasco, Carlos Panizo, Jose A. ...> ;Blood. 2020 Mar 26
• 37 citations
  A Phase I Study to Assess the Safety and Pharmacokinetics of Single-agent Lorvotuzumab Mertansine (IMGN901) in Patients with Relapsed and/or Refractory CD–56-positive ...
  Sikander Ailawadhi, Kevin R. Kelly, Robert Vescio, Sundar Jagannath, Jeffrey L. Wolf, Mecide Gharibo, Taimur Sher, Leyla Bojanini, Maurice Kirby, Asher Chanan-Khan> ;Clinical Lymphoma, Myeloma & Leukemia. 2019 Jan 1
• 21 citations
  A phase I/II study of KW-2478, an Hsp90 inhibitor, in combination with bortezomib in patients with relapsed/refractory multiple myeloma.
  James D. Cavenagh, Heather Oakervee, P Baetiong-Caguioa, Faith E. Davies, Mecide Gharibo, Neil Rabin, Michael R. Kurman, Barbara A. Novak, Norihiko Shiraishi, Daisuke ...> ;British Journal of Cancer. 2017 Oct 24
• 3 citations
  Choline-magnesium trisalicylate modulates acute myelogenous leukemia gene expression during induction chemotherapy
  Daniel J. Medina, Kevin A. David, Yong Lin, Dale G. Schaar, Vimal Patel, Mecide Gharibo, Rajat Bannerji, Kelly Walton, Joseph Aisner, Arnold B. Rabson, Roger Strair> ;Leukemia & Lymphoma. 2017 May 4
• 27 citations
  Lactobacillus rhamnosus GG probiotic enteric regimen does not appreciably alter the gut microbiome or provide protection against GVHD after allogeneic hematopoietic st...
  Elan Gorshein, Catherine Wei, Susan Ambrosy, Shanna Budney, Juliana Vivas, Angelika Shenkerman, Jacqueline Manago, Mary Kate McGrath, Anne Tyno, Yong Lin, Vimal Patel,...> ;Clinical Transplantation. 2017 May 1
• 533 citations
  Daratumumab monotherapy in patients with treatment-refractory multiple myeloma (SIRIUS): an open-label, randomised, phase 2 trial
  Sagar Lonial, Brendan M. Weiss, Saad Z. Usmani, Seema Singhal, Ajai Chari, Nizar J. Bahlis, Andrew Belch, Amrita Krishnan, Robert Vescio, Maria-Victoria Mateos, Amitab...> ;The Lancet. 2016 Apr 9
• 1 citations
  Accelerated R-COP: a pilot study for the treatment of advanced low grade lymphomas that has a high complete response rate.
  M.J. Levitt, Mecide Gharibo, Roger Strair, Dale G. Schaar, A. Rubin, Joseph R. Bertino> ;Journal of Chemotherapy. 2009 Aug 1
• 13 citations
  A pilot study of allogeneic cellular therapy for patients with advanced hematologic malignancies.
  Daniel J. Medina, Mecide Gharibo, Philip Savage, Alan Cohler, Mercy Kuriyan, Binaifer Balsara, Monika Anand, Dale G. Schaar, Tracy Krimmel, Kara Saggiomo, Jacqueline M...> ;Leukemia Research. 2008 Dec 1
• 13 citations
  Nuclear Factor-κB Modulation in Patients Undergoing Induction Chemotherapy for Acute Myelogenous Leukemia
  Roger K. Strair, Mecide Gharibo, Dale G. Schaar, A. Rubin, Jonathan S. Harrison, Joseph Aisner, Hsin-Ching Lin, Yong Lin, Lauri Goodell, Monika Anand, Binaifer Balsara...> ;Clinical Cancer Research. 2008 Nov 15
• 19 citations
  A phase II trial of imatinib mesylate in patients with metastatic pancreatic cancer.
  Mecide Gharibo, Linda Patrick-Miller, Ling Zheng, Lisa Guensch, Parisa Juvidian, Elizabeth Poplin> ;Pancreas. 2008 May 1
• 11 citations
  Sequential topoisomerase targeting and analysis of mechanisms of resistance to topotecan in patients with acute myelogenous leukemia.
  Biren Saraiya, Murugesan Gounder, Jayeeta Dutta, Ahamed Saleem, Celeste Collazo, Luz Zimmerman, Ahamed S. Nazar, Mecide Gharibo, Dale G. Schaar, Yong Lin, Weichung Shi...> ;Anti-Cancer Drugs. 2008 Apr 1
• 25 citations
  Phase I and Pharmacokinetic Study of Imatinib Mesylate (Gleevec) and Gemcitabine in Patients with Refractory Solid Tumors
  Yaqoob Ali, Yong Lin, Mecide Gharibo, Murugesan Gounder, Mark N. Stein, Theodore F. Lagattuta, Merrill J. Egorin, Eric H. Rubin, Elizabeth Poplin> ;Clinical Cancer Research. 2007 Oct 1
• Join now to see all